Cargando…
The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia
Olanzapine is an efficacious antipsychotic drug often used in the treatment for schizophrenia or bipolar disorder, however, sometimes induces metabolic disorders. We will introduce a patient with bipolar disorder, who has been treated by olanzapine and showed severe hypertriglyceridemia. As a result...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376879/ https://www.ncbi.nlm.nih.gov/pubmed/22719807 http://dx.doi.org/10.4021/jocmr802w |
_version_ | 1782235888593403904 |
---|---|
author | Adachi, Hiroki Yanai, Hidekatsu Hirowatari, Yuji |
author_facet | Adachi, Hiroki Yanai, Hidekatsu Hirowatari, Yuji |
author_sort | Adachi, Hiroki |
collection | PubMed |
description | Olanzapine is an efficacious antipsychotic drug often used in the treatment for schizophrenia or bipolar disorder, however, sometimes induces metabolic disorders. We will introduce a patient with bipolar disorder, who has been treated by olanzapine and showed severe hypertriglyceridemia. As a result of measurements of parameters associated with lipid metabolism, very-low density lipoprotein was most important lipoprotein for olanzapin-induced hypertriglyceridemia. The cessation of olanzapine significantly decreased high-sensitivity C-reactive protein and increased adiponectin, proposing that inflammation and reduced adiponectin level may be associated with olanzapin-induced hypertriglyceridemia. |
format | Online Article Text |
id | pubmed-3376879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-33768792012-06-20 The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia Adachi, Hiroki Yanai, Hidekatsu Hirowatari, Yuji J Clin Med Res Case Report Olanzapine is an efficacious antipsychotic drug often used in the treatment for schizophrenia or bipolar disorder, however, sometimes induces metabolic disorders. We will introduce a patient with bipolar disorder, who has been treated by olanzapine and showed severe hypertriglyceridemia. As a result of measurements of parameters associated with lipid metabolism, very-low density lipoprotein was most important lipoprotein for olanzapin-induced hypertriglyceridemia. The cessation of olanzapine significantly decreased high-sensitivity C-reactive protein and increased adiponectin, proposing that inflammation and reduced adiponectin level may be associated with olanzapin-induced hypertriglyceridemia. Elmer Press 2012-06 2012-05-15 /pmc/articles/PMC3376879/ /pubmed/22719807 http://dx.doi.org/10.4021/jocmr802w Text en Copyright 2012, Adachi et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Adachi, Hiroki Yanai, Hidekatsu Hirowatari, Yuji The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia |
title | The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia |
title_full | The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia |
title_fullStr | The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia |
title_full_unstemmed | The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia |
title_short | The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia |
title_sort | underlying mechanisms for olanzapine-induced hypertriglyceridemia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376879/ https://www.ncbi.nlm.nih.gov/pubmed/22719807 http://dx.doi.org/10.4021/jocmr802w |
work_keys_str_mv | AT adachihiroki theunderlyingmechanismsforolanzapineinducedhypertriglyceridemia AT yanaihidekatsu theunderlyingmechanismsforolanzapineinducedhypertriglyceridemia AT hirowatariyuji theunderlyingmechanismsforolanzapineinducedhypertriglyceridemia AT adachihiroki underlyingmechanismsforolanzapineinducedhypertriglyceridemia AT yanaihidekatsu underlyingmechanismsforolanzapineinducedhypertriglyceridemia AT hirowatariyuji underlyingmechanismsforolanzapineinducedhypertriglyceridemia |